{"title":"WEIGHT LOSS","description":null,"products":[{"product_id":"ozempic","title":"OZEMPIC","description":"\u003cp dir=\"auto\" data-start=\"422\" data-end=\"621\" class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong data-start=\"422\" data-end=\"445\"\u003eProduct Information\u003c\/strong\u003e\u003cbr data-start=\"445\" data-end=\"448\"\u003eOzempic® contains \u003cstrong data-start=\"466\" data-end=\"481\"\u003esemaglutide\u003c\/strong\u003e, a GLP-1 receptor agonist manufactured by Novo Nordisk. It is administered by subcutaneous injection and is used under medical supervision.\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" data-start=\"623\" data-end=\"647\"\u003e\u003cstrong data-start=\"623\" data-end=\"647\"\u003eApproved Indications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"648\" data-end=\"1179\"\u003e\n\u003cli data-start=\"648\" data-end=\"762\"\u003eAs an adjunct to diet and exercise to improve blood-glucose control in \u003cstrong data-start=\"721\" data-end=\"761\"\u003eadults with type 2 diabetes mellitus\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli data-start=\"763\" data-end=\"965\"\u003eTo reduce the risk of \u003cstrong data-start=\"787\" data-end=\"818\"\u003emajor cardiovascular events\u003c\/strong\u003e—including cardiovascular death, non-fatal heart attack, or non-fatal stroke—in adults with type 2 diabetes and established cardiovascular disease.\u003c\/li\u003e\n\u003cli data-start=\"966\" data-end=\"1179\"\u003eTo reduce the risk of \u003cstrong data-start=\"990\" data-end=\"1082\"\u003esustained decline in kidney function, end-stage kidney disease, and cardiovascular death\u003c\/strong\u003e in adults with type 2 diabetes and chronic kidney disease. \u003cspan class=\"contents\" data-content-reference-start=\"1137\" data-content-reference-end=\"1169\"\u003e\u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"1181\" data-end=\"1208\"\u003e\u003cstrong data-start=\"1181\" data-end=\"1208\"\u003eKey Therapeutic Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1209\" data-end=\"1599\"\u003e\n\u003cli data-start=\"1209\" data-end=\"1311\"\u003eHelps improve glycemic control in adults with type 2 diabetes when used alongside diet and exercise.\u003c\/li\u003e\n\u003cli data-start=\"1312\" data-end=\"1442\"\u003eProvides cardiovascular risk reduction for the indicated population with type 2 diabetes and established cardiovascular disease.\u003c\/li\u003e\n\u003cli data-start=\"1443\" data-end=\"1599\"\u003eProvides kidney-related risk reduction for the indicated population with type 2 diabetes and chronic kidney disease. \u003cspan class=\"contents\" data-content-reference-start=\"1552\" data-content-reference-end=\"1571\"\u003e\u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"1601\" data-end=\"1620\"\u003e\u003cstrong data-start=\"1601\" data-end=\"1620\"\u003eProduct Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1621\" data-end=\"2040\"\u003e\n\u003cli data-start=\"1621\" data-end=\"1642\"\u003e\n\u003cstrong data-start=\"1623\" data-end=\"1633\"\u003eBrand:\u003c\/strong\u003e Ozempic®\u003c\/li\u003e\n\u003cli data-start=\"1643\" data-end=\"1679\"\u003e\n\u003cstrong data-start=\"1645\" data-end=\"1667\"\u003eActive ingredient:\u003c\/strong\u003e Semaglutide\u003c\/li\u003e\n\u003cli data-start=\"1680\" data-end=\"1712\"\u003e\n\u003cstrong data-start=\"1682\" data-end=\"1699\"\u003eManufacturer:\u003c\/strong\u003e Novo Nordisk\u003c\/li\u003e\n\u003cli data-start=\"1713\" data-end=\"1753\"\u003e\n\u003cstrong data-start=\"1715\" data-end=\"1730\"\u003eDrug class:\u003c\/strong\u003e GLP-1 receptor agonist\u003c\/li\u003e\n\u003cli data-start=\"1754\" data-end=\"1808\"\u003e\n\u003cstrong data-start=\"1756\" data-end=\"1772\"\u003eDosage form:\u003c\/strong\u003e Solution for subcutaneous injection\u003c\/li\u003e\n\u003cli data-start=\"1809\" data-end=\"1842\"\u003e\n\u003cstrong data-start=\"1811\" data-end=\"1830\"\u003eAdministration:\u003c\/strong\u003e Once weekly\u003c\/li\u003e\n\u003cli data-start=\"1843\" data-end=\"1991\"\u003e\n\u003cstrong data-start=\"1845\" data-end=\"1869\"\u003eAvailable strengths:\u003c\/strong\u003e 0.5mg\u003c\/li\u003e\n\u003cli data-start=\"1992\" data-end=\"2040\"\u003e\n\u003cstrong data-start=\"1994\" data-end=\"2018\"\u003ePrescription status:\u003c\/strong\u003e Prescription medicine\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"2042\" data-end=\"2521\"\u003e\u003cstrong data-start=\"2042\" data-end=\"2074\"\u003eImportant Safety Information\u003c\/strong\u003e\u003cbr data-start=\"2074\" data-end=\"2077\"\u003eOzempic carries important warnings and contraindications. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and people with serious hypersensitivity to semaglutide or its ingredients. Reported common adverse reactions include nausea, vomiting, diarrhea, abdominal pain, and constipation.\u003c\/p\u003e","brand":"brunodermalfiller.com","offers":[{"title":"Default Title","offer_id":50431337988353,"sku":null,"price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0617\/7062\/9377\/files\/Ozempic-Semaglutide-Injection-0.25-mg-by-Novo-Nordisk-NDC-00169-4181-13_491d186a-803e-4d03-8242-1f7c825e6e6e.webp?v=1790786310"},{"product_id":"compound-semaglutide","title":"COMPOUND SEMAGLUTIDE","description":"\u003cp\u003e\u003cstrong\u003eProduct Category:\u003c\/strong\u003e Prescription GLP-1 medication\u003cbr\u003e\u003cstrong\u003eActive Ingredient:\u003c\/strong\u003e Semaglutide\u003cbr\u003e\u003cstrong\u003eFormulation:\u003c\/strong\u003e Compounded semaglutide\u003cbr\u003e\u003cstrong\u003eProvider:\u003c\/strong\u003e Willow\u003c\/p\u003e\n\u003ch3\u003eProduct Overview\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in certain prescription treatment plans. Willow describes its compounded semaglutide formulation as a personalized treatment option developed in conjunction with a patient's healthcare provider as part of an individualized care plan.\u003c\/p\u003e\n\u003cp\u003eCompounded formulations may be prepared to address specific patient needs when an FDA-approved medication is not medically appropriate or commercially available. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before being marketed.\u003c\/p\u003e\n\u003ch3\u003eActive Ingredient\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSemaglutide belongs to the GLP-1 receptor agonist class. FDA-approved semaglutide products have specific approved indications and formulations; a compounded semaglutide preparation should not be represented as an FDA-approved product or as an FDA-approved generic equivalent.\u003c\/p\u003e\n\u003ch3\u003eFormulation \u0026amp; Personalization\u003c\/h3\u003e\n\u003cp\u003eAccording to the supplied Willow information, the formulation is intended to be incorporated into an individualized treatment plan determined with a Willow healthcare professional.\u003c\/p\u003e\n\u003cp\u003eIt is available in \u003cstrong\u003e5MG\u003c\/strong\u003e but the exact concentration, dosage form, ingredients, and formulation characteristics should be verified against the current prescription label and documentation upon purchase.\u003c\/p\u003e\n\u003ch3\u003eRegulatory Information\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e Compounded semaglutide is \u003cstrong\u003enot FDA-approved\u003c\/strong\u003e. FDA does not conduct premarket review of compounded medications for safety, effectiveness, or quality. Compounded medications are also not equivalent to FDA-approved generic drugs.\u003c\/p\u003e\n\u003cp\u003eThe regulatory requirements and oversight applicable to a compounded medication depend on the type of compounding facility and applicable federal and state requirements. State-licensed pharmacies are generally subject to state board of pharmacy oversight, while FDA-registered outsourcing facilities are subject to additional federal oversight.\u003c\/p\u003e\n\u003ch3\u003eSafety \u0026amp; Quality Considerations\u003c\/h3\u003e\n\u003cp\u003eBecause compounded semaglutide formulations can differ in concentration, container, and presentation, accurate prescribing and dispensing information is particularly important. FDA has reported dosing errors associated with compounded injectable semaglutide, including errors involving different concentrations and measurement units.\u003c\/p\u003e\n\u003cp\u003ePatients should use prescription medicines only under the direction of an appropriately qualified healthcare professional and should refer to the dispensing pharmacy's labeling and accompanying medical instructions.\u003c\/p\u003e\n\u003ch3\u003eImportant Notice\u003c\/h3\u003e\n\u003cp\u003eThis information is provided for product identification and general educational purposes only. It does not replace the prescribing information, pharmacy labeling, or advice of a qualified healthcare professional.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"brunodermalfiller.com","offers":[{"title":"Default Title","offer_id":50433220018433,"sku":null,"price":199.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0617\/7062\/9377\/files\/6a3ad194f14ba4fb789370e9_pdp-semaglutide-signature.webp?v=1790789640"},{"product_id":"retratrutide","title":"RETATRUTIDE","description":"\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct category:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Peptide compound\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eListed strength:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 10 mg\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide, also known as LY3437943, is A peptide-based molecule developed by Eli Lilly and Company. It is studied for its activity at three hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis combined receptor activity has made retatrutide a subject of clinical research into metabolic regulation, body-weight management, and related health conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eScientific Background\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide is known for its potential effects on metabolic and glycemic outcomes. Its clinical development program has included studies involving adults with obesity or overweight, type 2 diabetes, and selected obesity-associated conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePublished and reported clinical findings relate to the investigational molecule administered under clinical-study conditions. They should not be interpreted as proof of the identity, purity, safety, or efficacy of an independently sourced vial.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eProduct Specifications\u003c\/span\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eName:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Retatrutide\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eListed quantity:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e 10 mg\u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eStorage and handling:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Follow only verified supplier documentation applicable to the specific batch and formulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"brunodermalfiller.com","offers":[{"title":"Default Title","offer_id":50433422590209,"sku":null,"price":105.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0617\/7062\/9377\/files\/RetatrutideResearchVialProductShot.png?v=1791905700"}],"url":"https:\/\/brunodermalfiller.com\/en-pt\/collections\/weight-loss.oembed","provider":"brunodermalfiller.com","version":"1.0","type":"link"}